Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2026-03-13 @ 8:31 PM
Study NCT ID:
NCT00997334
Status:
COMPLETED
Last Update Posted:
2018-02-23
First Post:
2009-10-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC
Sponsor:
David M. Jackman, MD
Organization: